IP Library Granted Patent US 11,096,760
Granted Patent B2
US 11,096,760 · App. 17/028,593 · Granted Aug 24, 2021

Methods and systems for controlled deployment of needles in tissue

Inventors: Michael Munrow (Belmont, CA); Jordan Bajor (Palo Alto, CA); Malcolm G. Munro (Tarzana, CA)
Assignee: Gynesonics, Inc.
A61B90/36A61B10/0045A61B18/1477A61M5/46A61B90/11A61B2010/045A61B2018/1425A61B2034/107A61B2090/378
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,096,760
App. No.
17/028,593
Granted
Aug 24, 2021
Kind
B2
Abstract

Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.

Claims (36)

1. A method for treating uterine anatomy, the method comprising:

positioning an ultrasound imaging device proximate to the uterine anatomy;

using the ultrasound imaging device to provide a real-time image of the uterine anatomy including a uterine fibroid to be treated;

advancing a radiofrequency ablation device into tissue of the uterine anatomy, wherein a projected path of a needle of the radiofrequency ablation device is overlaid onto the real-time ultrasound image as the radiofrequency ablation device is being manipulated relative to the uterine fibroid to be treated;

deploying a needle array comprising multiple needles from the radiofrequency ablation device into the uterine fibroid, wherein:

a projected treatment boundary or projected treatment volume based on a position of the needle array is overlaid onto the real-time ultrasound image of the uterine anatomy; and

the projected treatment boundary or projected treatment volume is recalculated based on an actual position of the needle array deployed into the uterine fibroid; and

after the projected treatment boundary or projected treatment volume is recalculated, treating the uterine fibroid by delivering radiofrequency energy through the needle array with at least a portion of the uterine fibroid positioned within the recalculated projected treatment boundary or projected treatment volume on the real-time ultrasound image.

2. The method of claim 1 , wherein the projected treatment boundary or projected treatment volume based on a position of the needle array is overlaid onto the real-time ultrasound image of the uterine anatomy prior to deploying the needle array into the uterine fibroid.

3. The method of claim 2 , wherein a system controller calculates the projected path of the needle of the radiofrequency ablation device and the projected treatment boundary or projected treatment volume.

4. The method of claim 3 , wherein the system controller prevents the delivering of radiofrequency energy until receipt of confirmation indicative of treatment being safe or effective.

5. A method for treating uterine anatomy, the method comprising:

overlaying a real-time ultrasound image of the uterine anatomy including an anatomical feature to be treated with projected needle treatment information of a tissue treatment device positioned proximate to the uterine anatomy, wherein the tissue treatment device comprises one or more needles, wherein the projected needle treatment information is predicted based on a deployed position of the one or more needles and wherein the projected needle treatment information includes a projected treatment boundary surrounding a portion of the one or more needles when in the deployed position;

aligning the projected needle treatment information on the real-time ultrasound image with the anatomical feature to be treated such that at least a portion of the anatomical feature to be treated is within the projected treatment boundary;

recalculating the projected treatment boundary based on an actual position of the one or more needles deployed into the anatomical feature to be treated; and

delivering energy through the one or more needles to treat the anatomical feature after aligning the projected needle treatment information on the real-time ultrasound image and with the one or more needles deployed into the anatomical feature to be treated and after recalculating the projected treatment boundary.

6. The method of claim 5 , comprising overlaying the projected treatment boundary onto the real-time ultrasound image after the one or more needles of the tissue treatment device are deployed into the anatomical feature.

7. The method of claim 5 , comprising overlaying the projected treatment boundary onto the real-time ultrasound image before the one or more needles of the tissue treatment device are deployed into the anatomical feature to be treated.

8. The method of claim 5 , wherein the anatomical feature to be treated comprises a uterine fibroid.

9. The method of claim 5 , further comprising overlaying onto the real-time ultrasound image a projected needle deployment path.

10. The method of claim 5 , further comprising overlaying onto the real-time ultrasound image a safety boundary based on a deployed position of the one or more needles of the tissue treatment device.

11. A method for treating uterine anatomy, the method comprising:

overlaying a real-time ultrasound image of the uterine anatomy including an anatomical feature to be treated with a projected needle path of a tissue treatment device positioned proximate to the uterine anatomy, wherein the tissue treatment device comprises one or more needles;

overlaying onto the real-time ultrasound image of the uterine anatomy a projected treatment boundary or projected treatment volume based on a deployed position of the one or more needles of the tissue treatment device, wherein at least a portion of the anatomical feature to be treated is within the projected treatment boundary or projected treatment volume;

recalculating the projected treatment boundary or projected treatment volume based on an actual position of the one or more needles deployed into the anatomical feature to be treated; and

delivering energy through the one or more needles to treat the anatomical feature after the projected treatment boundary or projected treatment volume is overlaid onto the real-time ultrasound image and with the one or more needles deployed into the anatomical feature to be treated and after the projected treatment boundary or projected treatment volume is recalculated.

12. The method of claim 11 , wherein the tissue treatment device comprises an array of multiple needles.

13. The method of claim 11 , comprising overlaying the projected treatment boundary or projected treatment volume onto the real-time ultrasound image after the one or more needles are deployed into the anatomical feature to be treated.

14. The method of claim 11 , comprising overlaying the projected treatment boundary or projected treatment volume onto the real-time ultrasound image before the one or more needles are deployed into the anatomical feature to be treated.

15. The method of claim 11 , wherein the projected needle path and the projected treatment boundary or projected treatment volume are overlaid simultaneously onto the real-time ultrasound image.

16. The method of claim 15 , further comprising overlaying the projected treatment boundary or projected treatment volume onto the real-time ultrasound image while the projected needle path is being manipulated relative to the anatomical feature to be treated.

17. The method of claim 11 , wherein the projected treatment boundary or projected treatment volume surrounds a portion of the one or more needles when in the deployed position.

18. The method of claim 17 , wherein the projected treatment boundary or projected treatment volume has an oval shape.

19. The method of claim 11 , wherein the projected needle path and the projected treatment boundary or projected treatment volume are overlaid onto an image of the one or more needles of the tissue treatment device.

20. The method of claim 11 , wherein the anatomical feature to be treated comprises a uterine fibroid.

21. The method of claim 11 , further comprising overlaying onto the real-time ultrasound image a safety boundary based on the deployed position of the one or more needles of the tissue treatment device.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2020
From: MUNROW, MICHAEL; BAJOR, JORDAN; MUNRO, MALCOLM G.
To: GYNESONICS, INC.
Reel/Frame 053849/0284 →
Cited By (1)
US 12,616,549